{"id":"W2094303174","doi":"10.3389/fphar.2015.00090","title":"Will drug resistance against dolutegravir in initial therapy ever occur?","year":2015,"lang":"en","type":"review","venue":"Frontiers in Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dolutegravir; Elvitegravir; Raltegravir; Integrase; Integrase inhibitor; Drug resistance; Pharmacology; Medicine; Virology; Human immunodeficiency virus (HIV); Biology; Antiretroviral therapy; Genetics; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006369347,0.0003183763,0.0008323903,0.0007645174,0.0001719964,0.0007702275,0.0004410862,0.001099529,0.003714421],"category_scores_gemma":[0.0007843251,0.0001592471,0.000428257,0.0006667983,0.0004037363,0.001179841,0.0004137661,0.00150592,0.001922681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004345597,"about_ca_system_score_gemma":0.0006505356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000520972,"about_ca_topic_score_gemma":0.001399662,"domain_scores_codex":[0.9998245,0.00004374261,0.00002348677,0.00003014577,0.00005821227,0.00002000024],"domain_scores_gemma":[0.9997566,0.0001259299,0.00004437501,0.000006971558,0.00004924746,0.0000168515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007862864,0.00003809055,0.0002148588,0.008694865,0.00006624492,0.0002148498,0.00006904153,0.0001449997,0.001504916,0.004662233,0.02333877,0.9609724],"study_design_scores_gemma":[0.00002934402,0.00012873,0.0007656912,0.003731451,0.0001101837,0.00265883,0.00008011013,0.00009811995,0.0007476566,0.002306403,0.9893273,0.00001618634],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002831946,0.9963428,0.0001376321,0.0009418912,0.0002120732,0.000004609841,0.00002193158,0.000005827574,0.002049986],"genre_scores_gemma":[0.002126915,0.9952845,0.0002094112,0.0007842655,0.0002515097,0.000006001216,0.00003253661,0.000002138716,0.001302731],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003714421,"threshold_uncertainty_score":0.01242596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04704367438094377,"score_gpt":0.3870412380498732,"score_spread":0.3399975636689294,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}